General Mills voluntarily recalled several types of Gold Medal flour for potential Salmonella contamination on Friday after the risk was identified during a random sampling of the 5-pound flour bags.
The 2-pound, 5-pound, and 10-pound bags of both bleached and unbleached Gold Medal all-purpose flour are subject to the recall.
Salmonella infections are most commonly caused by improper cleaning of food manufacturing tools and cooktops and from consuming raw or undercooked food.
Per the FDA, cooking, baking, boiling, and frying kill Salmonella.
According to the CDC, an estimated 1.35 million people get infected with Salmonella every year. Common symptoms include fever, intense indigestion, abdominal pain, and nausea, which can appear within six hours of eating contaminated food, but can also take up to six days to show up.
This isn't the first time General Mills has dealt with an outbreak.
In May 2016, General Mills recalled 10 million pounds of flour due to an E. Coli scare.
Thirty-eight people across 20 states reported feeling sick after consuming the brand's uncooked flour. After a few months, the recalled quantity grew to 45 million pounds after investigators detected E. coli in flour obtained from customers.


RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul
How to support someone who is grieving: five research-backed strategies
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Why have so few atrocities ever been recognised as genocide?
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
U.S. Stock Futures Hold Steady After S&P 500 and Nasdaq Hit Record Highs
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
The pandemic is still disrupting young people’s careers 



